Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at December 31, 2013:
- 31,724 shares of Innate Pharma, and
- 301,816.06 euros in cash
As a reminder, at June 30, 2013, the following assets appeared on the liquidity account:
- 75,277 shares of Innate Pharma, and
- 184,719.98 euros in cash
| PR in English | 28.94 KB |
| CP en français | 28.67 KB |